The study, which is expected to be published later this month in science journal
Nature Medicine, showed that 90 per cent of participants who received MDMA during therapy experienced a significantly greater reduction in the severity of their symptoms compared with those who received therapy and an inactive placebo.
After two months after treatment, 67 per cent of participants in the MDMA group no longer qualified for a diagnosis of PTSD, compared with 32 per cent in the placebo group. The study also found that MDMA produces no serious side effects, except mild symptoms like nausea and loss of appetite.
“This is about as excited as I can get about a clinical trial,” Gul Dolen, a neuroscientist at Johns Hopkins University School of Medicine, told
/PRNewswire/ Global Institute of Stem Cell Therapy and Research (GIOSTAR), the pioneer in the field of stem cell science and regenerative medicine, was.
BHCOE Announces ABAI 47th Annual Convention Symposiums and Presentations
Share Article
Behavioral scientists from Behavioral Health Center of Excellence to present at the virtual Association for Behavior Analysis International (ABAI) 47th Annual Convention.
ABAI’s Annual Conference plays a vital role in the research, education, and practice of behavior analysis, and I’m excited for the many contributions BHCOE team members are making this year. LOS ANGELES, Calif. (PRWEB) May 04, 2021 Nine behavioral scientists from Behavioral Health Center of Excellence co-authored research papers on thirteen topics related to the science and practice of behavior analysis, all of which will be presented at the virtual Association for Behavior Analysis International (ABAI) 47th Annual Convention held May 28-31st. Since 1974, ABAI has been the primary membership organization for those interested in the philosophy, science, ap
The group’s board members voted on April 1 to dissolve the charity, lay off its staff and donate its remaining assets to a number of local organizations.